Correlation Between Pfizer and At Equity
Can any of the company-specific risk be diversified away by investing in both Pfizer and At Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and At Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and At Equity Income, you can compare the effects of market volatilities on Pfizer and At Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of At Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and At Equity.
Diversification Opportunities for Pfizer and At Equity
Excellent diversification
The 3 months correlation between Pfizer and AWYIX is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and At Equity Income in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on At Equity Income and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with At Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of At Equity Income has no effect on the direction of Pfizer i.e., Pfizer and At Equity go up and down completely randomly.
Pair Corralation between Pfizer and At Equity
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the At Equity. In addition to that, Pfizer is 2.18 times more volatile than At Equity Income. It trades about -0.03 of its total potential returns per unit of risk. At Equity Income is currently generating about -0.05 per unit of volatility. If you would invest 6,059 in At Equity Income on November 27, 2024 and sell it today you would lose (36.00) from holding At Equity Income or give up 0.59% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. At Equity Income
Performance |
| Timeline |
| Pfizer Inc |
| At Equity Income |
Pfizer and At Equity Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and At Equity
The main advantage of trading using opposite Pfizer and At Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, At Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in At Equity will offset losses from the drop in At Equity's long position.| Pfizer vs. Emergent Biosolutions | Pfizer vs. Bausch Health Companies | Pfizer vs. Neurocrine Biosciences | Pfizer vs. Teva Pharma Industries |
| At Equity vs. Amana Growth Fund | At Equity vs. Amana Developing World | At Equity vs. Iman Fund Class | At Equity vs. Azzad Ethical Fund |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |